Liontrust Investment Partners’s Natus Medical Inc NTUS Stock Holding History

Liontrust Investment Partners’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,540	Closed	-$1.82M	–	272
2022 Q2	$1.82M	Sell	55,540 -56,500	-50%	-$1.79M	0.03%	201
2022 Q1	$2.94M	Hold	112,040	–	–	0.04%	145
2021 Q4	$2.66M	Hold	112,040	–	–	0.03%	158
2021 Q3	$2.81M	Buy	+112,040	New	+$2.85M	0.04%	150
2020 Q4	$3.59M	Buy	+178,940	New	+$3.5M	0.07%	125

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Liontrust Investment Partners's NTUS Position: Q3 2022 in Review

Liontrust Investment Partners sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 55,540 shares — an estimated $1.82M sold.

Liontrust Investment Partners first reported a position in NTUS in Q4 2020 and held it in 5 quarters. The position peaked at $3.59M in Q4 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Liontrust Investment Partners reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Liontrust Investment Partners sold 55,540 Natus Medical Inc shares in Q3 2022, an estimated $1.82M.
Liontrust Investment Partners first reported a position in Natus Medical Inc in Q4 2020 and held it in 5 quarters.
Liontrust Investment Partners's Natus Medical Inc position peaked at $3.59M in Q4 2020.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Liontrust Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.